The term “DIDMOAD” syndrome – an acronym for the characteristic symptoms – serves as an alternative name for this autosomal recessive neurodegenerative disease, which was first described in 1938: Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy and Deafness/Deafness. In the majority of patients, mutations in the WFS1 gene can be detected.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- MASLD/MASH
Drug therapy options on the rise: spectacular evidence
- New ways of neuroregeneration
CRISPR and artificial intelligence
- Asbestos victims
Federal Council has decided to amend the UVG
- Music as a cure for cancer?
Music therapy in Swiss oncology
- Clinical significance, pathophysiology, diagnosis and management
Frailty in COPD
- Bladder infections and urinary tract infections
Survey reveals information deficits in the population
- Early detection of type 1 diabetes
Detection of insulin autoantibodies as an early marker
- Type 2 diabetes